Articles that mention Valeant Pharmaceuticals -BoardProspects

Valeant Pharmaceuticals

0 Comments Leave a Comment

1-15 of 37 1 2 3 »
1. Mentioned In 37 Articles
2. Carl Icahn Discloses a Stake in Bausch Health Stock. What It Means.
  
  Explore Financial Investment News Feb 12 2021 BoardBlogs
  
  ... Hedge funds Paulson & Co. and ValueAct Capital have been longtime shareholders of Bausch, which was known as Valeant Pharmaceuticals until it changed its name in 2018 following accounting and price-gouging scandals. Bil...
  Read Full Article
  
  Comment
  
  Mentions: KKR Valeant Pharmaceuticals stake
3. Highlights from SEC Speaks 2020
  
  Explore National Law Review Oct 13 2020 BoardNews
  
  ...P measures as well as more traditional areas of financial fraud. Ms. Bandy identified the SEC’s cases against Valeant Pharmaceuticals and BGC Partners as recent examples of non-GAAP-related enforcement actions. She ident...
  Read Full Article
  
  Comment
  
  Mentions: Conference Investment Management
4. What We Can Learn From Bill Ackman's Comeback
  
  Explore gurufocus.com Jun 17 2019 BoardBlogs
  
  ...em Ackman's problems in 2016 and 2015 were well publicized. He decided to bet heavily on pharmaceutical group Valeant Pharmaceuticals, which at one point was his most significant single position. But after peaking in sum...
  Read Full Article
  
  Comment
  
  Mentions: Valeant Pharmaceuticals stake Square
5. Stoke Therapeutics Appoints Jennifer Burstein to its Board of Directors
  
  Explore businesswire.com Jun 14 2019 BoardMoves
  
  ...ore that, she worked on the finance team at Eyetech Pharmaceuticals, Inc., which is currently a subsidiary of Valeant Pharmaceuticals International, Inc. Earlier in her career, Ms. Burstein worked in the finance departme...
  Read Full Article
  
  Comment
  
  Mentions: Twitter acquisition Valeant Pharmaceuticals
6. Bill Ackman's Pershing Square is up More Than 24% So Far This Year
  
  Explore Yahoo Finance Feb 13 2019 BoardNews
  
  ...ent in 2018. Some of Pershing's challenges over the past few years included a $4 billion loss on its stake in Valeant Pharmaceuticals. Ackman's short of nutritional supplement company Herbalife proved costly not only in ...
  Read Full Article
  
  Comment
  
  Mentions: Hedge Fund Hilton ADP
7. LifePoint Board OK with $120 Million Pay Plan Despite Shareholder Rejection
  
  Explore modernhealthcare.com Nov 3 2018 BoardNews
  
  ...irectors and executives, unless they're structured in a way that doesn't permit changes. One example was when Valeant Pharmaceuticals' CEO agreed to forgo a massive stock award after shareholders expressed opposition.“So...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management Attorneys
8. Starbucks Spikes After Hedge-Fund Billionaire Bill Ackman Discloses a Stake in the Company
  
  Explore Stock Market Data Today Oct 9 2018 BoardNews
  
  ...another billionaire investor, who was bullish on the company. He also saw big losses on a position he held in Valeant Pharmaceuticals. Reuters reported in January that Ackman sought to lower his profile and turn around h...
  Read Full Article
  
  Comment
  
  Mentions: Conference Management Hedge Fund
9. Nestle Puts Skin-Health Unit Up for Possible $8 Billion Sale -
  
  Explore BNN Bloomberg Sep 20 2018 BoardNews
  
  ...ut in 2014 and in the following months paid a further $1.4 billion to buy a portfolio of skin-care drugs from Valeant Pharmaceuticals. This week Nestle agreed to sell Gerber Life Insurance to Western & Southern Financial...
  Read Full Article
  
  Comment
  
  Mentions: Sale Nestle Valeant Pharmaceuticals
10. Is This the End of Activist Investing?
  
  Explore FoxBusiness.com Apr 6 2018 BoardBlogs
  
  ...lar rate this year, one source told the WSJ. Ackman has recently made a few bad bets, including Herbalife and Valeant Pharmaceuticals. But while Pershing Square is reportedly seeing investors cash out, overall shareholde...
  Read Full Article
  
  Comment
  
  Mentions: Management General Motors Greenlight Capital
11. Has Bill Ackman Lost His Touch? Pershing Investors Say Yes
  
  Explore Fool.com Apr 5 2018 BoardBlogs
  
  ...et earlier this year. Ackman has also made missteps on the bullish side of the spectrum. His calls supporting Valeant Pharmaceuticals International led to massive investments from Pershing Square in the controversial pha...
  Read Full Article
  
  Comment
  
  Mentions: Management Hedge Fund Valeant Pharmaceuticals
12. Three Activist Hedge Funds to Watch
  
  Explore Stock Market Today Jan 23 2018 BoardBlogs
  
  ... Oplink Communications, Obagi Medical Products Inc., and Solta Medical Inc. Solta and Obagi were both sold to Valeant Pharmaceuticals International Inc. for significant premiums, helping drive Voce's returns. Land & Buil...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management Hedge Fund
13. Jeffrey Ubben Joins AES Board of Directors
  
  Explore businesswire.com Jan 18 2018 BoardMoves
  
  ...of Twenty-First Century Fox Inc., and is a former Director of Gartner Group, Inc., Misys plc, Sara Lee Corp., Valeant Pharmaceuticals International and Willis Towers Watson plc, as well as other public and private compan...
  Read Full Article
  
  Comment
  
  Mentions: Management KKR Twitter
14. Valeant CEO Papa says Drugmaker has 'Turnaround Opportunity of a Lifetime'
  
  Explore bnn.ca Jan 10 2018 BoardNews
  
  ...d during a presentation Wednesday at the J.P. Morgan Healthcare Conference in San Francisco... (Bloomberg) -- Valeant Pharmaceuticals International Inc. became a household name with its historic rise and fall. Reviving t...
  Read Full Article
  
  Comment
  
  Mentions: Conference Valeant Pharmaceuticals stake
15. Pershing Square, Valeant asked to appear for hearing on insider trading suit (VRX, Agn)
  
  Explore Stock Market Data Today Jan 3 2018 BoardNews
  
  ...iscuss the proposed settlement in an insider trading lawsuit. Jan 2 (Reuters) - A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a ...
  Read Full Article
  
  Comment
  
  Mentions: Management lawsuit Valeant Pharmaceuticals
16. Top Canadian CEOs made more than 200 times average worker — study
  
  Explore Jamaica Observer Jan 3 2018 BoardNews
  
  ... highest paid among them were raking in record-breaking earnings,” said the report's author, David Macdonald. Valeant Pharmaceuticals' CEO Joseph Papa was the best paid in 2016, making Can$83.1 million in eight months on...
  Read Full Article
  
  Comment
  
  Mentions: Valeant Pharmaceuticals stock options Crisis
17. 1-15 of 37 1 2 3 »